Target intelligence / Profile preview

Chloride intracellular channel protein 5 (CLIC5)

Target: CLIC5
Molecular classification: Ion channel (intracellular chloride channel family), Other (has glutaredoxin-like thiol-disulfide exchange activity)

Overview

Chloride intracellular channel protein 5 (CLIC5) is a member of the CLIC family of intracellular chloride channels. Unlike classical plasma membrane chloride channels, CLIC5 can transition between soluble and membrane-associated forms, enabling unique ion channel and enzymatic functions. It is highly expressed in specialized cells such as podocytes in the renal glomerulus and inner ear hair cells, where it is critical for maintaining cellular structure, facilitating actin-membrane interactions, and ensuring proper function of the filtration barrier and hearing apparatus. CLIC5 has at least two major isoforms (CLIC5A and CLIC5B) and interacts with cytoskeletal and membrane proteins such as ezrin and podocalyxin-like protein. Mutations or loss of CLIC5 function are associated with hearing loss and renal disease. Its roles in cancer and as a prognostic biomarker are emerging research areas. Pharmaceutical modulation of CLIC5 is limited by a lack of highly selective channel inhibitors and unresolved controversies about its precise physiological channel activity.

Other names: CLIC5ACLIC5Bp64p62 (avian ortholog)Chloride intracellular channel 5

Mechanism of action

Inhibition of chloride and cation conductance (IAA-94 and A9C) Inhibition of enzymatic/thiol-transferase activity (IAA-94 and A9C)

Biological functions

Regulation of actin-based cytoskeleton structuresCell architecture maintenance (e.g., podocyte and endothelial cell integrity)Formation of stereocilia in cochlear hair cells (hearing)Maintenance of glomerular filtration (renal physiology)Cell membrane fusion (fusogenic activity)Modulation of phosphorylation events impacting cytoskeleton-membrane coupling

Disease associations

Sensorineural deafness (autosomal recessive non-syndromic deafness, especially DFNB103)Glomerular disorders (glomerular podocyte injury, nephrotic syndrome)Cancer (role as prognostic biomarker and contribution to invasion/migration in hepatocellular carcinoma)Hypertension-induced glomerular injury

Safety considerations

Disruption of CLIC5 function leads to hearing loss (due to stereocilia malformation and degeneration of hair cells)Knock-out models show susceptibility to glomerular disease; there is a risk of renal dysfunction if targeted therapeuticallyNotable for limited selectivity of known pharmacological inhibitors; can affect other intracellular chloride channels

Interacting drugs

IAA-94 (chloride channel blocker)

2 more in the full profile.

Biomarkers

Co-expression with EZR and PODXL in hepatocellular carcinoma, used as a prognostic indicatorMay be used with other podocyte markers in kidney injury/disease

Beyond the preview

Go deeper on Chloride intracellular channel protein 5 (CLIC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride intracellular channel protein 5 (CLIC5).

Explore the full profile